Metagenomic next-generation sequencing assists in the diagnosis of visceral leishmaniasis in non-endemic areas of China

IntroductionLeishmaniasis, a protozoan disease caused by infection by Leishmania, is a critical issue in Asia, South America, East Africa, and North Africa. With 12 million cases globally, leishmaniasis is one of the most serious neglected tropical diseases worldwide. Direct identification of infect...

Full description

Saved in:
Bibliographic Details
Main Authors: Rui Zhao, Guilun He, Lin Xiang, Melinda Ji, Rongheng He, Xudong Wei
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2025.1517046/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832087107698425856
author Rui Zhao
Guilun He
Lin Xiang
Melinda Ji
Rongheng He
Xudong Wei
author_facet Rui Zhao
Guilun He
Lin Xiang
Melinda Ji
Rongheng He
Xudong Wei
author_sort Rui Zhao
collection DOAJ
description IntroductionLeishmaniasis, a protozoan disease caused by infection by Leishmania, is a critical issue in Asia, South America, East Africa, and North Africa. With 12 million cases globally, leishmaniasis is one of the most serious neglected tropical diseases worldwide. Direct identification of infected tissues is currently the primary method of diagnosis; however, the low sensitivity and inconvenience of microscopic examination in detecting amastigotes, parasitic manifestations of Leishmania, leads to the possibility of misdiagnosis, delayed diagnosis, and underdiagnosis.MethodsWith the development of metagenomic nextgeneration sequencing (mNGS) technology for pathogen identification, it is possible to detect specific nucleic acid sequences characteristic of Leishmania parasites, which opens new avenues for the more accurate diagnosis of leishmaniasis. In this study, we report two cases of leishmaniasis from Henan Province, China, in which Leishmania parasites were identified using mNGS technology, massively expediting diagnosis and treatment.ResultsOur report demonstrates that the mNGS method is applicable to peripheral blood samples (PB), which are far more readily available in clinical settings, in addition to bone marrow aspirate samples (BM), which are traditionally used for diagnosis of visceral leishmaniasis.ConclusionOur report validates the efficacy of mNGS technology as a rapid and accurate method of diagnosis for leishmaniasis.
format Article
id doaj-art-36111bf2393f49ab9b2451ce76024ca0
institution Kabale University
issn 2235-2988
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj-art-36111bf2393f49ab9b2451ce76024ca02025-02-06T07:09:26ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882025-02-011510.3389/fcimb.2025.15170461517046Metagenomic next-generation sequencing assists in the diagnosis of visceral leishmaniasis in non-endemic areas of ChinaRui Zhao0Guilun He1Lin Xiang2Melinda Ji3Rongheng He4Xudong Wei5Department of Hematopathy, Henan Institute of Hematology, Cancer Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, ChinaScience and Technology Service Center, Nanjing Practice Medicine Diagnostics CO., Ltd., Nanjing, Jiangsu, ChinaScience and Technology Service Center, Nanjing Practice Medicine Diagnostics CO., Ltd., Nanjing, Jiangsu, ChinaDepartment of Translational Research and Cellular Therapeutics, City of Hope, Duarte, CA, United StatesDepartment of Hematopathy, Henan Institute of Hematology, Cancer Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, ChinaDepartment of Hematopathy, Henan Institute of Hematology, Cancer Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, ChinaIntroductionLeishmaniasis, a protozoan disease caused by infection by Leishmania, is a critical issue in Asia, South America, East Africa, and North Africa. With 12 million cases globally, leishmaniasis is one of the most serious neglected tropical diseases worldwide. Direct identification of infected tissues is currently the primary method of diagnosis; however, the low sensitivity and inconvenience of microscopic examination in detecting amastigotes, parasitic manifestations of Leishmania, leads to the possibility of misdiagnosis, delayed diagnosis, and underdiagnosis.MethodsWith the development of metagenomic nextgeneration sequencing (mNGS) technology for pathogen identification, it is possible to detect specific nucleic acid sequences characteristic of Leishmania parasites, which opens new avenues for the more accurate diagnosis of leishmaniasis. In this study, we report two cases of leishmaniasis from Henan Province, China, in which Leishmania parasites were identified using mNGS technology, massively expediting diagnosis and treatment.ResultsOur report demonstrates that the mNGS method is applicable to peripheral blood samples (PB), which are far more readily available in clinical settings, in addition to bone marrow aspirate samples (BM), which are traditionally used for diagnosis of visceral leishmaniasis.ConclusionOur report validates the efficacy of mNGS technology as a rapid and accurate method of diagnosis for leishmaniasis.https://www.frontiersin.org/articles/10.3389/fcimb.2025.1517046/fullmetagenomic next-generation sequencing assiststherapyleishmaniasisendemic areaclinical diagnosis
spellingShingle Rui Zhao
Guilun He
Lin Xiang
Melinda Ji
Rongheng He
Xudong Wei
Metagenomic next-generation sequencing assists in the diagnosis of visceral leishmaniasis in non-endemic areas of China
Frontiers in Cellular and Infection Microbiology
metagenomic next-generation sequencing assists
therapy
leishmaniasis
endemic area
clinical diagnosis
title Metagenomic next-generation sequencing assists in the diagnosis of visceral leishmaniasis in non-endemic areas of China
title_full Metagenomic next-generation sequencing assists in the diagnosis of visceral leishmaniasis in non-endemic areas of China
title_fullStr Metagenomic next-generation sequencing assists in the diagnosis of visceral leishmaniasis in non-endemic areas of China
title_full_unstemmed Metagenomic next-generation sequencing assists in the diagnosis of visceral leishmaniasis in non-endemic areas of China
title_short Metagenomic next-generation sequencing assists in the diagnosis of visceral leishmaniasis in non-endemic areas of China
title_sort metagenomic next generation sequencing assists in the diagnosis of visceral leishmaniasis in non endemic areas of china
topic metagenomic next-generation sequencing assists
therapy
leishmaniasis
endemic area
clinical diagnosis
url https://www.frontiersin.org/articles/10.3389/fcimb.2025.1517046/full
work_keys_str_mv AT ruizhao metagenomicnextgenerationsequencingassistsinthediagnosisofvisceralleishmaniasisinnonendemicareasofchina
AT guilunhe metagenomicnextgenerationsequencingassistsinthediagnosisofvisceralleishmaniasisinnonendemicareasofchina
AT linxiang metagenomicnextgenerationsequencingassistsinthediagnosisofvisceralleishmaniasisinnonendemicareasofchina
AT melindaji metagenomicnextgenerationsequencingassistsinthediagnosisofvisceralleishmaniasisinnonendemicareasofchina
AT ronghenghe metagenomicnextgenerationsequencingassistsinthediagnosisofvisceralleishmaniasisinnonendemicareasofchina
AT xudongwei metagenomicnextgenerationsequencingassistsinthediagnosisofvisceralleishmaniasisinnonendemicareasofchina